2013.07.15 Weekly Broadcast Email

There following updates were made to the CCCWF CCOP Research Base website for the week of July 15, 2013. 


99211 Announcement:
(Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A Pilot Study)

Please be aware if a patient is enrolled in protocol 99211 the following requirements for SAE’s are defined in Section 10.2 of the protocol.  Grades 3, 4 and 5 SAE’s meeting the criteria for a Medwatch need to be reported in both the Quitline Intervention Group and the Usual Care Group. If you have patients in which a Medwatch needs to be submitted, please do so as soon as possible.

 


13th Annual Meeting Registration:

The CCCWF CCOP Research Base 13th Annual Meeting will be held October 24-26 in Asheville, NC.  Please visit our annual meeting website for the meeting agenda, accommodation information, and registration.  We look forward to seeing you in October!

 


98110:
(A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)

The 2013 Continuing Review WF Approval Letter has been posted to the website.

 

Thank you

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 07-22-2013
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.